Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

Abstract Background NK cells are the most active innate immune cells in antiviral immunity, which are impaired by SARS-COV2 infection. Infusion of allogeneic NK cells might be a complementary treatment to boost immune system function in COVID-19 patients. In this project, we focused on COVID-19 pati...

Full description

Bibliographic Details
Main Authors: Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi, Hassan Sanati, Fereshteh Abbasvandi, Masud Yunesian, Keivan Majidzadeh-A, Jalil Makarem, Hamid Reza Aghayan, Atefeh Abedini, Ardeshir Ghavamzadeh, Ramin Sarrami Forooshani
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Pilot and Feasibility Studies
Subjects:
NK cells
COVID-19
Pneumonia
Online Access:https://doi.org/10.1186/s40814-023-01355-6

Internet

https://doi.org/10.1186/s40814-023-01355-6

Similar Items